Patents

RECENT NEWS
MedPage Today  Aug 18  Comment 
(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff
The Hindu Business Line  Aug 17  Comment 
Suven Life Sciences on Thursday informed the exchanges that it has secured process patents from Europe, Japan and New Zealand for new chemical entities (NCEs) used for the treatment of disorders assoc...
The Hindu Business Line  Aug 15  Comment 
Global drug major Takeda Pharmaceuticals has dragged two Indian drug firms — Granules India and Hetero Drugs — to court over charges of patent infringement of its drug to treat Gout and Familial Medi...
FiercePharma  Aug 14  Comment 
A decade in biopharma has a way of featuring megablockbuster patent losses—and we mean mega. The whopper? Humira, with its 2016 patent loss and $179 billion in lifetime sales. All together, the biggest drugs losing IP protections since 2007 will...
MarketWatch  Aug 14  Comment 
Crocs, which has been embroiled in a patent case against USA Dawgs since 2006, had its complaint rejected by the U.S. Patent and Trademark Office




 
TOP CONTRIBUTORS

Patents

Patent is the right to ownership,as part of an intellectual property law, where by a person / organization discovers a lesser known concept or invents something new and holds sole intellectual ownership rights to that particular idea. These are usually published / granted after a lot of research and exhaustive verification. Patents are generally registered with United States Patent and Trademark Office, an Agency Of The United States Department Of Commerce, in the United States and The Intellectual Property Office,a division of the Department for Innovation, Universities & Skills in the United Kingdom.

Technological Patents

Pharmaceutical Patents

Pharmaceutical patents protect manufacturers of prescription drugs, prohibiting others from producing a drug during the length of its patent protection. The length of these patents varies in different countries, though they are usually between 15-20 years. In the U.S., a pharmaceutical patent is valid for 20 years. Drug companies usually apply for patent protection before they actually begin producing the drug, opting instead to secure their rights to a particular compound at the beginning of the testing process. By the time a drug comes to market, there may only be 8-10 years of patent protection remaining, which is significantly less than the 20 offered by the patent. Companies often attempt to extend these patents by making slight reformulations of the original compound or proving its effectiveness at treating a condition other than the one for which it was originally granted a patent. This is referred to as "evergreening", a practice which many criticize.

For further information on the process of obtaining pharmaceutical patents and regulatory approval, see Clinical Trials and FDA Approval.

For more information about pharmaceutical patents in relation to generic versions of drugs, see Generic Drugs.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki